Swissmedic examines drugs trialled by GVK Biosciences
The Swiss surveillance authority for medicines Friday checked for any corresponding preparations of the 700 generic medicines subjected to clinical trials by India's GVK Biosciences, whose marketing rights were suspended by the European Medicines Agency (EMA).
Feb 07, 2015, 00:59 AM IST
GVK Bio under scanner of European Drug Regulator
The European Medicines Agency (EMA) has started a review in connection with findings of alleged non-compliance with good clinical practice (GCP) at a facility owned by GVK Biosciences, a city-based Contract Research Organisation.
Oct 01, 2014, 17:29 PM IST
